Loading...

H. Lundbeck A/S

HLUBF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.97
$0.38(8.28%)

H. Lundbeck A/S (HLUBF) Stock Overview

Explore H. Lundbeck A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap4.9B
P/E Ratio9.13
EPS (TTM)$0.55
ROE0.14%
Fundamental Analysis

AI Price Forecasts

1 Week$3.70
1 Month$4.04
3 Months$3.06
1 Year Target$4.94

HLUBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of H. Lundbeck A/S (HLUBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.76, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $4.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 9.13 and a market capitalization of 4.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.14%
5-Day Change
-9.06%
1-Month Change
-15.75%
3-Month Change
-17.27%
6-Month Change
-35.02%
Year-to-Date (YTD) Change
-17.27%
1-Year Change
-11.90%
3-Year Change
-3.55%
5-Year Change
-3.55%
All-Time (Max) Change
-3.55%

Contact Information

https://www.lundbeck.com
45 36 30 13 11
Ottiliavej 9, Valby, 2500

Company Facts

5,707 Employees
IPO DateJul 13, 2022
CountryDK
Actively Trading

Frequently Asked Questions

;